<DOC>
	<DOC>NCT01190553</DOC>
	<brief_summary>This is a pilot study for Maintenance Intravenous Treatment with AMANTADINE in patient with PARKINSON'S Disease who are not well balanced with medical treatment.</brief_summary>
	<brief_title>Pilot Study of Maintenance Therapy With Intravenous AMANTADINE</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Amantadine</mesh_term>
	<criteria>Patients with idiopathic Parkinson disease Age&lt;80 Patients with no motor improvement under optimal treatment with anti parkinson medications Patients with moderate to severe dyskinesias Patients with PD with side effects who can not tolerate anti parkinson medications Age&gt;80 Patients with Parkinson syndromes, vascular parkinsonism or druginduced parkinsonism Patients with PD who developed adverse reactions to oral amantadine Contraindication of amantadine treatment</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>amantadine</keyword>
	<keyword>parkinson disease</keyword>
	<keyword>dyskinesia</keyword>
</DOC>